In this nationwide phase @-@ cluster-randomised , double-blind trial , children younger than @ months were randomly assigned to receive PHiD-CV@ in @ of @ clusters or hepatitis B or A vaccine as control in @ clusters according to three plus one or two plus one schedules ( infants younger than @ months ) or catch-up schedules ( children aged @-@ months ) .